tiprankstipranks
Lexston Life Sciences Corp. (TSE:LEXT)
:LEXT
Canadian Market

Lexston Life Sciences Corp. (LEXT) Financial Statements

Compare
6 Followers

Lexston Life Sciences Corp. Financial Overview

Lexston Life Sciences Corp.'s market cap is currently C$2.85M. The company's EPS TTM is C$-0.374; its P/E ratio is ―; Lexston Life Sciences Corp. is scheduled to report earnings on April 15, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 361.01KC$ 149.11KC$ 0.00
Gross ProfitC$ -26.39KC$ -29.80KC$ 241.49KC$ 60.10KC$ 0.00
Operating IncomeC$ -674.72KC$ -871.53KC$ -1.86MC$ -106.04KC$ -6.48K
EBITDAC$ -648.32KC$ -841.73KC$ -1.89MC$ -479.82KC$ -6.48K
Net IncomeC$ -867.71KC$ -1.11MC$ -2.32MC$ -876.13KC$ -6.48K
Balance Sheet
Cash & Short-Term InvestmentsC$ 390.40KC$ 511.00KC$ 590.49KC$ 949.17KC$ 170.76K
Total AssetsC$ 750.95KC$ 814.30KC$ 952.80KC$ 1.10MC$ 170.95K
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -390.40KC$ -511.00KC$ -590.49KC$ -949.17KC$ -170.76K
Total LiabilitiesC$ 39.87KC$ 11.21KC$ 79.09KC$ 38.81KC$ 1.96K
Stockholders' EquityC$ 711.08KC$ 803.10KC$ 873.71KC$ 1.06MC$ 168.99K
Cash Flow
Free Cash FlowC$ -723.16KC$ -987.74KC$ -1.40MC$ -608.63KC$ -4.71K
Operating Cash FlowC$ -523.18KC$ -987.74KC$ -1.40MC$ -483.16KC$ -4.71K
Investing Cash FlowC$ -199.99KC$ 0.00C$ -109.97KC$ 812.32KC$ 0.00
Financing Cash FlowC$ 602.57KC$ 908.24KC$ 1.15MC$ 620.01KC$ 175.47K
Currency in CAD

Lexston Life Sciences Corp. Earnings and Revenue History

Lexston Life Sciences Corp. Debt to Assets

Lexston Life Sciences Corp. Cash Flow

Lexston Life Sciences Corp. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis